In addition, heterozygous loss-of-function mutations in the type II BMP receptor BMPR2, as well as in ALK1, ENG, and BMP9, have been identified in patients with pulmonary arterial hypertension (PAH)18–21. Here, GDF2 is linked to pulmonary arterial hypertension.